Literature DB >> 22648235

Cell delivery routes for stem cell therapy to the heart: current and future approaches.

Niall G Campbell1, Ken Suzuki.   

Abstract

An important factor to determine the success of stem cell therapy to the heart is the choice of cell delivery route. This will affect the fate of donor cells and subsequently influence the outcome of treatment; however, there is currently no optimum cell delivery route appropriate for every disease condition or every donor cell type. This review summarises currently available approaches for administering cells to the heart, with a particular focus on cell retention/survival and the therapeutic benefits seen in preclinical and clinical studies. Two major approaches are intracoronary and intramyocardial injection, which have been widely used for the delivery of various types of cells. Although there are advantages to both approaches, donor cell retention and survival are poor using these methods, potentially limiting therapeutic effects. Various attempts to improve current approaches, along with the development of emerging new approaches, are also described and discussed in this review.

Entities:  

Mesh:

Year:  2012        PMID: 22648235     DOI: 10.1007/s12265-012-9378-3

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  110 in total

Review 1.  Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.

Authors:  Peter Donndorf; Guenther Kundt; Alexander Kaminski; Can Yerebakan; Andreas Liebold; Gustav Steinhoff; Aenne Glass
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03-03       Impact factor: 5.209

2.  The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study.

Authors:  Bodo-Eckehard Strauer; Muhammad Yousef; Christiana M Schannwell
Journal:  Eur J Heart Fail       Date:  2010-07       Impact factor: 15.534

3.  Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.

Authors:  Jérôme Roncalli; Frédéric Mouquet; Christophe Piot; Jean-Noel Trochu; Philippe Le Corvoisier; Yannick Neuder; Thierry Le Tourneau; Denis Agostini; Virginia Gaxotte; Catherine Sportouch; Michel Galinier; Dominique Crochet; Emmanuel Teiger; Marie-Jeanne Richard; Anne-Sophie Polge; Jean-Paul Beregi; Alain Manrique; Didier Carrie; Sophie Susen; Bernard Klein; Angelo Parini; Guillaume Lamirault; Pierre Croisille; Hélène Rouard; Philippe Bourin; Jean-Michel Nguyen; Béatrice Delasalle; Gérald Vanzetto; Eric Van Belle; Patricia Lemarchand
Journal:  Eur Heart J       Date:  2010-12-02       Impact factor: 29.983

4.  Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

Authors:  Nabil Dib; Robert E Michler; Francis D Pagani; Susan Wright; Dean J Kereiakes; Rose Lengerich; Philip Binkley; Diane Buchele; Inder Anand; Cory Swingen; Marcelo F Di Carli; James D Thomas; Wael A Jaber; Shaun R Opie; Ann Campbell; Patrick McCarthy; Michael Yeager; Vasken Dilsizian; Bartley P Griffith; Ronald Korn; Steven K Kreuger; Marwan Ghazoul; W Robb MacLellan; Gregg Fonarow; Howard J Eisen; Jonathan Dinsmore; Edward Diethrich
Journal:  Circulation       Date:  2005-09-20       Impact factor: 29.690

5.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

6.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

Authors:  M A Konstam; M F Rousseau; M W Kronenberg; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

Authors:  Yoshinori Miyahara; Noritoshi Nagaya; Masaharu Kataoka; Bobby Yanagawa; Koichi Tanaka; Hiroyuki Hao; Kozo Ishino; Hideyuki Ishida; Tatsuya Shimizu; Kenji Kangawa; Shunji Sano; Teruo Okano; Soichiro Kitamura; Hidezo Mori
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

8.  Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.

Authors:  Caroline E Veltman; Osama I I Soliman; Marcel L Geleijnse; Wim B Vletter; Pieter C Smits; Folkert J ten Cate; Luc J Jordaens; Aggie H H M Balk; Patrick W Serruys; Eric Boersma; Ron T van Domburg; Wim J van der Giessen
Journal:  Eur Heart J       Date:  2008-04-25       Impact factor: 29.983

9.  Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

Authors:  Douglas W Losordo; Richard A Schatz; Christopher J White; James E Udelson; Vimal Veereshwarayya; Michelle Durgin; Kian Keong Poh; Robert Weinstein; Marianne Kearney; Muqtada Chaudhry; Aaron Burg; Liz Eaton; Lindsay Heyd; Tina Thorne; Leon Shturman; Peter Hoffmeister; Ken Story; Victor Zak; Douglas Dowling; Jay H Traverse; Rachel E Olson; Janice Flanagan; Donata Sodano; Toshinori Murayama; Atsuhiko Kawamoto; Kengo Fukushima Kusano; Jill Wollins; Frederick Welt; Pinak Shah; Peter Soukas; Takayuki Asahara; Timothy D Henry
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

10.  [Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function].

Authors:  José Suárez de Lezo; Concepción Herrera; Manuel Pan; Miguel Romero; Djordje Pavlovic; José Segura; Joaquín Sánchez; Soledad Ojeda; Antonio Torres
Journal:  Rev Esp Cardiol       Date:  2007-04       Impact factor: 4.753

View more
  24 in total

Review 1.  Stem cell death and survival in heart regeneration and repair.

Authors:  Eltyeb Abdelwahid; Audrone Kalvelyte; Aurimas Stulpinas; Katherine Athayde Teixeira de Carvalho; Luiz Cesar Guarita-Souza; Gabor Foldes
Journal:  Apoptosis       Date:  2016-03       Impact factor: 4.677

2.  Matrix-specific anchors: a new concept for targeted delivery and retention of therapeutic cells.

Authors:  Andrzej Steplewski; Jolanta Fertala; Pedro Beredjiklian; Mark L Wang; Andrzej Fertala
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

3.  Ultrasound-guided transthoracic intramyocardial injection in mice.

Authors:  Terence W Prendiville; Qing Ma; Zhiqiang Lin; Pingzhu Zhou; Aibin He; William T Pu
Journal:  J Vis Exp       Date:  2014-08-05       Impact factor: 1.355

4.  Cell surface glycoengineering improves selectin-mediated adhesion of mesenchymal stem cells (MSCs) and cardiosphere-derived cells (CDCs): Pilot validation in porcine ischemia-reperfusion model.

Authors:  Chi Y Lo; Brian R Weil; Beth A Palka; Arezoo Momeni; John M Canty; Sriram Neelamegham
Journal:  Biomaterials       Date:  2015-09-25       Impact factor: 12.479

5.  Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue Engineering and Therapy.

Authors:  Anwarul Hasan; Renae Waters; Boustany Roula; Rahbani Dana; Seif Yara; Toubia Alexandre; Arghya Paul
Journal:  Macromol Biosci       Date:  2016-03-08       Impact factor: 4.979

6.  Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart.

Authors:  Curtis C Hughey; Freyja D James; Lianli Ma; Deanna P Bracy; Zhizhang Wang; David H Wasserman; Jeffrey N Rottman; Jane Shearer
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

Review 7.  Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

Authors:  Pratik A Lalit; Derek J Hei; Amish N Raval; Timothy J Kamp
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

8.  Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study.

Authors:  Nobuko Tano; Takuya Narita; Masahiro Kaneko; Chiho Ikebe; Steven R Coppen; Niall G Campbell; Manabu Shiraishi; Yasunori Shintani; Ken Suzuki
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

Review 9.  Bone marrow-derived mesenchymal stem cells for the treatment of heart failure.

Authors:  Takuya Narita; Ken Suzuki
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

10.  Tracking the Fate of Muscle-derived Stem Cells: an Insight into the Distribution and Mode of Action.

Authors:  Hyung Sub Park; Geum Hee Choi; Soli Hahn; Young Sun Yoo; In Mok Jung; Taeseung Lee
Journal:  Vasc Specialist Int       Date:  2014-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.